Progestin regulation of vascular endothelial growth factor in human breast cancer cells

Cancer Research

Volumn 58, Issue 3, 1998, Pages 392-395

  Hyder, Salman M ^a,b   Murthy, Lata ^a   Stancel, George M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANGIOGENIC FACTOR; ANTIGESTAGEN; ESTROGEN DERIVATIVE; GESTAGEN; GLUCOCORTICOID; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; MIFEPRISTONE; NORETHISTERONE; NORETYNODREL; NORGESTREL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; VASCULOTROPIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SPECIFICITY; HORMONE ACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION;

BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOKINES; MEDROXYPROGESTERONE 17-ACETATE; MEGESTROL ACETATE; MIFEPRISTONE; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NORETHINDRONE; NORETHYNODREL; NORGESTREL; PROGESTERONE; PROGESTINS; RECEPTORS, PROGESTERONE; STIMULATION, CHEMICAL; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032005986     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kolch, W., Martiny-Baron, G., Kieser, A., and Marmé, D. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res. Treat., 36: 139-155, 1995.
2. Folkman, J. Angiogenesis and breast cancer J. Clin. Oncol., 12: 441-443, 1994.
3. Claffey, K. P., and Robinson, G. S. Regulation of vegf/vpf expression in tumor cells-consequences for tumor growth and metastasis. Cancer Metastasis Rev., 15: 165-176, 1996.
4. Toi, M., Kondo, S., Suzuki, H., Yamamoto, Y., Inada, K., Imazawa, T., Taniguchi, T., and Tominaga, T. Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer (Phila.), 77: 1101-1106, 1996.
5. Anan, K., Morisaki, T., Katano, M., Ikubo, A., Kitsuki, H., Uchiyama, A., Kuroki, S., Tanaka, M., and Torisu, M. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery (St. Louis), 119: 333-339, 1996.
6. Gasparini, G., Toi, M., Gion, M., Verderio, P., Dittadi, R., Hanatani, M., Matsubara, I., Vinante, O., Bonoldi, E., Boracchi, P., Gatti, C., Suzuki, H., and Tominaga, T. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. Natl. Cancer Inst., 89: 139-147, 1997.
7. Toi, M., Inada, K., Suzuki, H., and Tominaga, T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res. Treat., 36: 193-204, 1995.
8. Ferrara, N., and Davissmyth, T. The biology of vascular endothelial growth factor. Endocrine Rev., 18: 4-25, 1997.
9. Hyder, S. M., Stancel, G. M., Chiappetta, C., Murthy, L., Boettgertong, H. L., and Makela, S. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res., 56: 3954-3960, 1996.
10. Cullinan-Bove, K., and Koos, R. D. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology, 133: 829-837, 1993.
11. Nakamura, J., Savinov, A., Lu, Q., and Brodie, A. Estrogen regulates vascular endothelial growth permeability factor expression in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Endocrinology, 137: 5589-5596, 1996.
12. Gradishar, W. J., and Jordan, V. C. Clinical potential of new antiestrogens. J. Clin. Oncol., 15: 840-852, 1997.
13. Hyder, S. M., Stancel, G. M., and Loose-Mitchell, D. S. Presence of an estradiol response region in the mouse c-fos oncogene. Steroids, 56: 498-504, 1991.
14. Hyder, S. M., Shipley, G. L., and Stancel, G. M. Estrogen action in target cells: selective requirements for activation of different hormone response elements. Mol. Cell. Endocrinol., 112: 35-43, 1995.
15. Rochefort, H., and Chalbos, D. Progestin-specific markers in human cell lines: biological and pharmacological applications. Mol. Cell. Endocrinol., 36: 3-10, 1984.
16. Alkhalaf, M., and Murphy, L. C. Regulation of c-jun and jun-B by progestins in T-47D human breast cancer cells. Mol. Endocrinol., 6: 1625-1633, 1992.
17. Coutts, A., Murphy, L. J., and Murphy, L. C. Expression of insulin-like growth factor binding proteins by T47-D human breast cancer cells: regulation by progestins and antiestrogens. Breast Cancer Res. Treat., 32: 153-164, 1994.
18. Shifren, J. L., Tseng, J. F., Zaloudek, C. J., Ryan, I. P., Meng, Y. G., Ferrara, N., Jaffe, R. B., and Taylor, R. N. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium-implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab., 81: 3112-3118, 1996.
19. Fotherby. K. Pharmacokinetics and metabolism of progestins in humans. In: J. W. Goldzicher and K. Fotherby (eds.), Pharmacology of the Contraceptive Steroids, pp. 99-126. New York: Raven Press, 1994.
20. Vonier, P. M., Crain, D. A., McLachlan, J. A., Guillette, L. J., Jr., and Arnold, S. F. Interaction of environmental chemicals with the estrogen and progesterone receptors from the oviduct of the American alligator. Environ. Health Perspect., 104: 1318-1322, 1996.
21. Clarke, C. L., and Sutherland, R. L. Progestin regulation of cellular proliferation-update 1993 in Endocrine Reviews Monograph 1. In: A. Negro-Vilar and K. B. Horwitz (eds.), pp. 132-135. Bethesda, MD: The Endocrine Society, 1993.
22. Murphy, L. C., and Dotzlaw, H. Endogenous growth factor in T47-D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens. Cancer Res., 49: 599-604, 1989.
23. Shi, Y. E., Torri, J., Yieh, L., Sobel, M. E., Yamada, Y., Lippman, M. E., Dickson, R. B., and Thompson, E. W. Expression of 67-kDa lamimn receptor in human breast cancer cells: regulation by progestins. Clin. Exp. Metastasis, 11: 251-261, 1993.
24. Horwitz, K. B., Tung, L., and Takimoto, G. S. Novel mechanisms of antiprogestin action. Acta Oncol., 35: 129-140, 1996.
25. Bissett, D., Harnett, A. N., Canney, P. A., McMurray, A., Leake, R., George, W. D., Paul, J., and Kaye, S. B. Sequential tamoxifen and megestrol acetate with continuous norethisterone in postmenopausal breast cancer-feasibility study. Breast, 5: 92-95, 1997.
26. Yamaoka, M., Yamamoto, T., Ikeyama, S., Sudo, K., and Fujita, T. Angiogenesis inhibitor TNP-470 potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res., 53: 5233-5236, 1993.